{
  "created_at": "Mon Nov 08 22:53:29 +0000 2021",
  "id_str": "1457781232104660996",
  "full_text": "The drug will be used to treat patients who have not been vaccinated, or who remain at high risk despite having had a jab  https://t.co/e2jHXXc2Z9",
  "display_text_range": [
    0,
    146
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/e2jHXXc2Z9",
        "expanded_url": "https://econ.st/3GUuIUZ",
        "display_url": "econ.st/3GUuIUZ",
        "indices": [
          123,
          146
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 37,
  "favorite_count": 77,
  "possibly_sensitive": false,
  "original_created_at": "Mon Nov 08 18:45:04 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "この薬は、ワクチンを接種していない患者や、ワクチンを接種したにもかかわらず高いリスクを抱えている患者の治療に使用されます。https://t.co/e2jHXXc2Z9"
    },
    {
      "locale": "zh",
      "full_text": "该药物将用于治疗未接种疫苗的患者，或在接种后仍有高风险的患者https://t.co/e2jHXXc2Z9。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "該藥物將用於治療未接種疫苗的患者，或在接種後仍有高風險的患者https://t.co/e2jHXXc2Z9。"
    }
  ]
}